Literature DB >> 20207560

School performance in a cohort of children with CNS inflammatory demyelination.

Yann Mikaeloff1, Guillaume Caridade, Catherine Billard, Jean Bouyer, Marc Tardieu.   

Abstract

BACKGROUND: Acute CNS inflammatory demyelination in childhood may induce permanent cognitive impairment. However, there has been no epidemiological assessment of prognostic factors for school performance in a cohort of children with such a disease.
METHODS: The cohort consisted of 344 children from the French "KIDSEP" neuropediatric cohort with at least one clinically defined attack of CNS inflammatory demyelination occurring before the age of 16 years, and with at least two years of follow-up (inclusion from 1990 to 2003, follow-up until June 2007). We used multivariate survival analysis (Cox model) to evaluate the prognostic value for grade retention between the start of elementary school ( approximately 6 years of age) and the end of high school ( approximately 17-18 years of age), of variables related to both the socioeconomic status of the parents and the characteristics of the disease at onset.
RESULTS: The cohort was monitored for a mean of 8.0+/-3.4 years. Grade retention after disease onset was recorded for 151 patients (43.9%). The risk of grade retention was significantly higher for boys, children from families with lower social status and poorer housing conditions, children over the age of 11 years at disease onset and children suffering optic neuritis or brainstem dysfunction at the first attack or irreversible disability, even if only moderate, following the first attack.
CONCLUSIONS: The risk factors for poor school performance are related to low socioeconomic status and to factors predictive of a relapsing severe course of the disease, leading to the diagnosis of multiple sclerosis. Copyright (c) 2010 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20207560     DOI: 10.1016/j.ejpn.2010.02.003

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  7 in total

Review 1.  Therapies for multiple sclerosis: considerations in the pediatric patient.

Authors:  Brenda Banwell; Amit Bar-Or; Gavin Giovannoni; Russell C Dale; Marc Tardieu
Journal:  Nat Rev Neurol       Date:  2011-01-11       Impact factor: 42.937

2.  Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis.

Authors:  Gregory Aaen; Michael Waltz; Wendy Vargas; Naila Makhani; Jayne Ness; Yolanda Harris; T Charles Casper; Leslie Benson; Meghan Candee; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Benjamin Greenberg; Timothy Lotze; Soe Mar; Jan-Mendelt Tillema; Mary Rensel; Moses Rodriguez; John Rose; Jennifer Rubin; Teri Schreiner; Amy Waldman; Bianca Weinstock-Guttman; Anita Belman; Emmanuelle Waubant; Lauren Krupp
Journal:  J Child Neurol       Date:  2018-12-17       Impact factor: 1.987

3.  Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis.

Authors:  Cristina Fernandez-Carbonell; Leigh E Charvet; Lauren B Krupp
Journal:  Paediatr Drugs       Date:  2021-05-17       Impact factor: 3.022

Review 4.  Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices.

Authors:  I-Jun Chou; Huei-Shyong Wang; William P Whitehouse; Cris S Constantinescu
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

5.  Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study.

Authors:  Lauren Krupp; Brenda Banwell; Tanuja Chitnis; Kumaran Deiva; Jutta Gaertner; Angelo Ghezzi; Peter Huppke; Emmanuelle Waubant; Virginia DeLasHeras; Amin Azmon; Rajesh Karan
Journal:  BMJ Neurol Open       Date:  2022-02-24

6.  Utilization and Treatment Patterns of Disease-Modifying Therapy in Pediatric Patients with Multiple Sclerosis in the United States.

Authors:  Benjamin Greenberg; Scott Kolodny; Mengru Wang; Chinmay Deshpande
Journal:  Int J MS Care       Date:  2020-06-02

Review 7.  Recommendations for cognitive screening and management in multiple sclerosis care.

Authors:  Rosalind Kalb; Meghan Beier; Ralph Hb Benedict; Leigh Charvet; Kathleen Costello; Anthony Feinstein; Jeffrey Gingold; Yael Goverover; June Halper; Colleen Harris; Lori Kostich; Lauren Krupp; Ellen Lathi; Nicholas LaRocca; Ben Thrower; John DeLuca
Journal:  Mult Scler       Date:  2018-10-10       Impact factor: 6.312

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.